“It’s a bit like playing whack-a-mole,” said Peter Marks, FDA’s top official for biologic products.
Speaking at a conference last month, Marks described the frustration of trying to regulate a rapidly expanding — and morphing — industry. “There’s nothing more we would like to do than take more enforcement action,” he said. “But it’s a slow and deliberate process.”
Just read the last 2 sentences from FDA top official Peter Marks. You must remember GSCG does sell stem cell products world wide including the USA.
Yes FDA wants more enforcement actions thanks for the conformation!!!
News 
Market Data 
Discover 
